35.8 C
Tuesday, July 23, 2024

EU’s legal threats against AstraZeneca likely to end in failure

Judging by clauses contained in the unredacted vaccine procurement contract between the EU and AstraZeneca, the European Commission’s case against the Anglo-Swedish pharmaceutical company seems hopeless. We’ve asked legal experts for their verdict.

he European Commission’s legal threats against AstraZeneca for the delay in Covid-19 vaccine deliveries are likely to end in failure. This is what several clauses in the EU’s contract with the Anglo-Swedish company seem to confirm, according to legal experts with whom we shared the uncensored contract.

The most crucial provision, among those redacted in the document made public on January 27, states that “the European Commission and member states waive any claims against AstraZeneca for delays in delivery”.

According to Colin McCall, partner at international law firm Taylor Wessing, this leaves no doubt that the Commission’s claims are unfounded. Clive Douglas, attorney and commercial mediator at Nexa Law, agrees. The claims concern the 60 percent cut in doses scheduled for the first quarter of 2021, announced by AstraZeneca on 22 January.

Related news